mazdutide and tirzepatide together vs Research I compare two weight loss

The phase 3 TRIUMPH-4 trial recently reported average weight loss of up to 71.2 pounds

Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)

Additionally, Tirzepatide has shown efficacy in improving glycemic control in adults with type 2 diabetes

Semaglutide (Ozempic, Wegovy) Semaglutide has a slightly longer half-life of approximately seven days compared to tirzepatide five-day half-life